Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Using Google as a Source of Information About Breast Cancer

Tas F., Erturk K.
INDIAN JOURNAL OF SURGERY , cilt.85, sa.2, ss.473-475, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

Unknown Primary Metastatic Melanoma Presented with Extensive Subcutaneous Masses and Lymph Node Enlargements

Tas F., Erturk K.
INDIAN JOURNAL OF SURGERY , cilt.84, ss.579-580, 2022 (SCI-Expanded) identifier identifier

Larger Tumors Are Associated with Poorer Prognostic Factors in Cutaneous Melanoma

Tas F., Erturk K.
INDIAN JOURNAL OF SURGERY , cilt.84, sa.3, ss.591-594, 2022 (SCI-Expanded) identifier identifier

Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study

Tacar S. Y., Selcukbiricik F., Yilmaz M., Erturk K., Sarici A. M., Gulturk I., et al.
MELANOMA RESEARCH , cilt.31, sa.5, ss.449-455, 2021 (SCI-Expanded) identifier identifier identifier

Cutaneous melanoma in vicenarians: Patients in their twenties and older patients show similar clinical behaviors and survival rates

Tas F., Erturk K.
JOURNAL OF COSMETIC DERMATOLOGY , cilt.19, ss.2692-2696, 2020 (SCI-Expanded) identifier identifier identifier

Number of Excised Lymph Nodes Has No Impact on Relapse and Survival in Patients With Stage III Melanoma

Tas F., Erturk K.
ANNALS OF PLASTIC SURGERY , cilt.83, sa.4, ss.455-458, 2019 (SCI-Expanded) identifier identifier identifier

Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?

Erturk K., Karaman S., Dagoglu N., Serilmez M., Duranyildiz D., Tas F.
WIENER KLINISCHE WOCHENSCHRIFT , sa.17-18, ss.419-426, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

BRAF mutation status might contribute an effect on both disease-free and overall survival in stage III cutaneous melanomas treated with intermediate dose interferon-alpha

Tas F., Erturk K.
CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.84, sa.3, ss.521-526, 2019 (SCI-Expanded) identifier identifier identifier

The course of stage III melanoma in accordance with the severity of node involvement

Tas F., Erturk K.
CURRENT MEDICAL RESEARCH AND OPINION , cilt.35, sa.10, ss.1819-1824, 2019 (SCI-Expanded) identifier identifier identifier

Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma

Tas F., Erturk K.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.24, sa.6, ss.721-726, 2019 (SCI-Expanded) identifier identifier identifier

Early and late relapses of cutaneous melanoma patients

Tas F., Erturk K.
POSTGRADUATE MEDICINE , cilt.131, sa.3, ss.207-211, 2019 (SCI-Expanded) identifier identifier identifier

Cheek Cutaneous Melanomas A Review of 98 Cases

Tas F., Erturk K.
ANNALS OF PLASTIC SURGERY , cilt.82, sa.4, ss.407-410, 2019 (SCI-Expanded) identifier identifier identifier

Palpebral cutaneous melanomas: a review of 17 cases from a tertiary center

Tas F., Erturk K.
INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.58, sa.1, ss.75-79, 2019 (SCI-Expanded) identifier identifier identifier

Clinical significance of serum leptin level in patients with gastric cancer

Tas F., Karabulut S., Erturk K., Duranyildiz D.
EUROPEAN CYTOKINE NETWORK , cilt.29, sa.2, ss.52-58, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Anemia in Cutaneous Malignant Melanoma: Low Blood Hemoglobin Level is Associated with Nodal Involvement, Metastatic Disease, and Worse Survival

Tas F., Erturk K.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.70, sa.2, ss.236-240, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival

Tas F., Erturk K.
PATHOBIOLOGY , cilt.85, sa.4, ss.227-231, 2018 (SCI-Expanded) identifier identifier identifier

Digital clubbing as a first clinical presentation of pulmonary metastases in cutaneous melanoma

Tas F., Erturk K.
POSTGRADUATE MEDICINE , cilt.130, sa.2, ss.278-279, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Cutaneous Melanoma in Association With Ichthyosis Vulgaris

Tas F., Erturk K., DEMİRKESEN C., Goktay F.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.39, sa.8, ss.630, 2017 (SCI-Expanded) identifier identifier identifier

Scalp melanoma is associated with high mitotic rate and is a poor prognostic factor for recurrence and outcome

Tas F., Erturk K.
MELANOMA RESEARCH , cilt.27, sa.4, ss.387-390, 2017 (SCI-Expanded) identifier identifier identifier

Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors

Tas F., Erturk K.
MELANOMA RESEARCH , cilt.27, sa.2, ss.134-139, 2017 (SCI-Expanded) identifier identifier identifier

Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma

Tas F., Erturk K.
INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.56, sa.2, ss.166-170, 2017 (SCI-Expanded) identifier identifier identifier

Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients

Tas F., Erturk K.
CANCER INVESTIGATION , cilt.35, sa.8, ss.501-505, 2017 (SCI-Expanded) identifier identifier identifier

Clinical significance of serum claudin-1 levels in melanoma patients

Tas F., Bilgin E., Erturk K., Duranyildiz D.
MELANOMA RESEARCH , cilt.26, sa.4, ss.377-381, 2016 (SCI-Expanded) identifier identifier identifier

Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?

Erturk K., Tastekin D., Bilgin E., Serilmez M., Bozbey H. U., Sakar B.
BIOMEDICINE & PHARMACOTHERAPY , cilt.77, ss.86-91, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?

Erturk K., Tastekin D., Gundogdu G., Tas F., Vatansever S.
BIOMEDICINE & PHARMACOTHERAPY , cilt.77, ss.27-29, 2016 (SCI-Expanded) identifier identifier identifier

Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer

Erturk K., Tastekin D., Serilmez M., Bilgin E., Bozbey H. U., Vatansever S.
TUMOR BIOLOGY , cilt.37, sa.1, ss.405-412, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome

Karanlik H., Özgür I., Cabioglu N., Sen F., Erturk K., Kilic B., et al.
EJSO , cilt.41, sa.9, ss.1226-1233, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicity

Tastekin D., Tambas M., KILIC K., Erturk K., ARSLAN D.
INVESTIGATIONAL NEW DRUGS , cilt.32, sa.6, ss.1295-1300, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

Widespread finger skin metastases of melanoma

Tas F., Erturk K.
CLINICAL CASE REPORTS , cilt.6, sa.2, ss.448-449, 2018 (ESCI) identifier identifier

Effect of biology on the outcome of female melanoma patients

Erturk K., Tas F.
MOLECULAR AND CLINICAL ONCOLOGY , cilt.7, sa.6, ss.1093-1100, 2017 (ESCI) identifier identifier

Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma

Tas F., Erturk K.
MOLECULAR AND CLINICAL ONCOLOGY , cilt.7, sa.6, ss.1142-1146, 2017 (ESCI) Sürdürülebilir Kalkınma identifier identifier

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival

Tas F., Erturk K.
MOLECULAR AND CLINICAL ONCOLOGY , cilt.7, sa.6, ss.1083-1088, 2017 (ESCI) identifier identifier

Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma

Tas F., Bilgin E., Karabulut S., Erturk K., Duranyildiz D.
BBA CLINICAL , cilt.5, ss.166-169, 2016 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier

Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.
BIOMEDICAL REPORTS , cilt.4, sa.5, ss.609-614, 2016 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier

Clinical significance of serum laminin levels in patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.
BIOMEDICAL REPORTS , cilt.4, sa.4, ss.485-488, 2016 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier

Pankreas adenokarsinomlu hastalarda serum transforme edici büyüme factor beta 1 TGF B1 düzeyleri

KARABULUT S., KARABULUT M., AFŞAR USUL Ç., ALIŞ H., DAĞOĞLU N., AKARSU C., et al.
İstanbul Tıp Fakültesi Dergisi , cilt.79, sa.1, ss.9-15, 2016 (Hakemli Dergi)

SERUM TRANSFORMING GROWTH FACTOR BETA 1 (TGF-B1) LEVELS IN PANCREATIC ADENOCARCINOMA PATIENTS

Karabulut S., Karabulut M., Usul Afsar C., Alis H., Dagoglu N., Akarsu C., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , sa.1, ss.9-15, 2016 (ESCI) Sürdürülebilir Kalkınma identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Mide Kanserinde Serum Interleukin-29, Interleukin-32 ve Tumor Necrosis Factor Alpha'nın Klinik Önemi

ERTÜRK K., TAŞTEKİN D., SERİLMEZ M., BİLGİN DOĞRU E., H. U., VATANSEVER S.
3. Ulusal İmmüno-Onkoloji ve Hedefe Yönelik Kanser Tedavileri Kongresi, Antalya, Türkiye, 11 - 15 Mayıs 2016, ss.1 Sürdürülebilir Kalkınma

Diagnostic and prognostic roles of serum interleukin-32 (IL-32) levels in patients with pancreatic adenocarcinoma.

KARABULUT S., Afsar C. U., Yasasever V., Karabulut M., Erturk K., Alis H., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34 identifier

The role of adhesion molecules in hepatocellulary carcinoma

Tastekin D., DIKILITAS M., HARPUTLUOGLU H., Erturk K., CELEBI K., Sen F., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 identifier

Do serum nectin-2 levels have a prognostic effect in patients with colorectal cancer?

Basaran M., KARABULUT S., KARABULUT M., GUNALDI M., ALIS H., Erturk K., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 Sürdürülebilir Kalkınma identifier

Clinical significance of serum claudin-7 levels in patients with colorectal cancer.

Aydogan F., Karabulut M., Alis H., Karabulut S., Celebi K., Bozbey H. U., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 Sürdürülebilir Kalkınma identifier

Metrikler

Yayın

42

Atıf (WoS)

247

H-İndeks (WoS)

10

Atıf (Scopus)

236

H-İndeks (Scopus)

9

Proje

1
BM Sürdürülebilir Kalkınma Amaçları